Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
YS Biopharma Announces Receipt of Nasdaq Notice 2023-10-26 20:30
HanAll Biopharma Reports Third Quarter 2023 Financial Results and Provides a Business Update 2023-10-26 19:00
Fapon, LASCCO, Abionic Formed Strategic Collaboration for PSP Sepsis Diagnosis in China 2023-10-26 18:33
Biosyngen's BST02, the World's First TIL Therapy for Liver Cancer, is Granted an IND Approval by FDA 2023-10-26 18:18
Bridge Biotherapeutics Announces Positive Recommendation from the Independent Data Monitoring Committee of the BBT-877 Phase 2a Study in Idiopathic Pulmonary Fibrosis 2023-10-26 07:00
First Patient Dosed for MRCT Phase 3 Study on First-Line LS-SCLC of Henlius Anti-PD-1 mAb Serplulimab in Europe 2023-10-25 21:15
FDA Meeting Feedback Puts Turn Biotechnologies on Track to be First Longevity Company Taking Cell Rejuvenation Therapy to Clinic 2023-10-25 20:30
SEH Biotechnology: Revolutionizing the Global Beverage and Brewing Industry with Cutting-Edge Water and Biotech from Taiwan 2023-10-25 18:00
AMS BioteQ Makes Debut at Medical Japan 2023: Bringing Innovative Healthcare into New Horizons 2023-10-25 13:06
GC Cell Joins U.S Cancer Moonshot Project 2023-10-25 11:27
Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development 2023-10-25 04:18
Cyrus K. Mirsaidi Named Global CEO to Bridgewest Perth Pharma 2023-10-24 23:17
TidetronBioworks Illuminated in Global Spotlight at WFF 2023 for Sustainable Power 2023-10-24 22:31
First Immunotherapy Success in TKI-Resistant Lung Cancer Setting Demonstrates Power of AI-driven Immune Phenotyping by Lunit SCOPE IO - newly published in JCO 2023-10-24 21:00
Phase Ib/II Results of Akeso's PD-1/CTLA-4 Bispecific Antibody for First-Line Treatment of Advanced Hepatocellular Carcinoma Published at 2023 ESMO 2023-10-24 20:00
OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product 2023-10-24 12:05
Singapore-based Juniper Biologics Awarded the Most Innovative Oncology Pharmaceutical Company 2023 by GHP Healthcare and Pharmaceutical Awards 2023-10-24 12:00
Cellomics announces Mr. Andy A. Liu as new Group CEO of the Company 2023-10-24 12:00
Alphamab Oncology Announces New Data from Multiple Studies of KN046 with Lung Cancer and Thymic Carcinoma at ESMO 2023-10-24 08:41
LifeSpan Vision Ventures Invests in Matter Bio 2023-10-24 03:40
1 34 35 36 37 38 413